Fewer than 2% of youth who overdosed on opioids received pharmacotherapy with buprenorphine, naltrexone or methadone, a study found.
MORE THAN TWO-THIRDS OF teens and young adults who overdosed on opioids and survived did not receive timely evidence-based addiction treatment, according to a new study.
Researchers from across the U.S. used the 2009-2015 Truven-IBM Watson Health MarketScan Medicaid claims database to examine nonfatal opioid overdoses among youths between the ages of 13 and 22 in conjunction with receipt of timely addiction treatment, which they defined as “a claim for behavioral health services, for buprenorphine, methadone or naltrexone prescription or administration, or for both behavioral health services and pharmacotherapy within 30 days of incident overdose.”
They found that among 3,606 youths who survived an opioid overdose and remained enrolled in Medicaid in the seven-year period, 2,483 – 68.9% – did not receive addiction treatment within 30 days of their overdose, 1,056 (29.3%) received behavioral health services alone and only 1 in 54 (1.9%) received medication-assisted treatment.
Post expires and will no longer be available at 8:21 pm on Friday January 8th, 2021